Galectin Therapeutics GALT

$ 2.72 0.0%

Quarterly report 2024-Q3
added 11-14-2024

Galectin Therapeutics Total Assets 2011-2024 | GALT

Annual Total Assets Galectin Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
28.2 M	21.3 M	41.8 M	29.6 M	48.5 M	9.01 M	4.16 M	15.8 M	26.4 M	29.7 M	10.7 M	9.56 M	6.61 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
48.5 M	4.16 M	21.6 M

Quarterly Total Assets Galectin Therapeutics

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
29 M	27.7 M	25.9 M	28.2 M	22.2 M	20.1 M	20.2 M	21.3 M	17.9 M	25.9 M	33.6 M	41.8 M	38 M	33.4 M	22.9 M	29.6 M	29.6 M	29.6 M	29.6 M	48.5 M	48.5 M	48.5 M	48.5 M	9.01 M	9.01 M	9.01 M	9.01 M	4.16 M	4.16 M	4.16 M	4.16 M	15.8 M	15.8 M	15.8 M	15.8 M	26.4 M	26.4 M	26.4 M	26.4 M	29.7 M	29.7 M	29.7 M	29.7 M	10.7 M	10.7 M	10.7 M	10.7 M	9.56 M	9.56 M	9.56 M	9.56 M	6.61 M	6.61 M	6.61 M	6.61 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
48.5 M	4.16 M	21.2 M